首頁 > 雜志

Cancer Biology & Medicine(2016年04期)
癌癥生物學(xué)與醫(yī)學(xué)(英文版)

  • 基本信息
  • Clinical Oncology and Cancer Research;Chinese Journal of Clinical Oncology

    中國抗癌協(xié)會;天津醫(yī)科大學(xué)腫瘤醫(yī)院

    月刊

  • 2095-3941

    12-1431/R

    天津市

    英文;

    16開

    6-173

    2004

  • 出版信息
  • 醫(yī)藥衛(wèi)生科技

    腫瘤學(xué)

    1360篇

  • 33554次

    7386次

  • 評價信息
  • 2.314

    1.724

  • CA 化學(xué)文摘(美)(2024)

    SCI 科學(xué)引文索引(美)(2024)

    JST 日本科學(xué)技術(shù)振興機(jī)構(gòu)數(shù)據(jù)庫(日)(2024)

    CSCD 中國科學(xué)引文數(shù)據(jù)庫來源期刊(2023-2024年度)

    WJCI 科技期刊世界影響力指數(shù)報告(2023)來源期刊

    中國科技期刊卓越行動計劃入選項目;中國最具國際影響力學(xué)術(shù)期刊;

目 錄

  • Chinese Anti-Cancer Association
  • ELSEVIER‘S ONCOLOGY JOURNALS PUBLISH HIGH QUALITY RESEARCH
  • Liver cancer: challenge and prospect
  • Role of micro RNAs in inflammation-associated liver cancer
  • Portal vein embolization for induction of selective hepatic hypertrophy prior to major hepatectomy: rationale,techniques, outcomes and future directions
  • Three-dimensional printing: review of application in medicine and hepatic surgery
  • Portal vein tumor thrombus is a bottleneck in the treatment of hepatocellular carcinoma
  • Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients
  • Surgical treatment of intrahepatic cholangiocarcinoma: a retrospective study of 104 cases
  • Molecular landscape in acute myeloid leukemia: where do we stand in 2016
  • Human endogenous retroviruses and cancer
  • Properties and feasibility of using cancer stem cells in clinical cancer treatment
  • Ki-67 as a prognostic marker according to breast cancer molecular subtype
  • Leptin influences estrogen metabolism and increases DNA adduct formation in breast cancer cells
  • Work-up and management of a high-risk patient with primary central nervous system lymphoma
  • Call for Paper
  • Cancer Biology & Medicine Indexed in PubMed
客服微信二維碼

掃碼添加客服微信

聯(lián)系客服